Humlebæk, Denmark company Aage Louis-Hansen founded in 1957; makes ostomy, urology, continence and wound care products and is listed on Nasdaq Copenhagen as COLO B.
Market cap $16.4B on 21 Nov 2026
| Fundsmith LLP | Terry Smith | 4 | 2023–2026 |
| Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2026 | Terry Smith explains changes to how Fundsmith Equity is run after a 2.9% fall in the first half of 2026, and exits 13 holdings including Novo Nordisk, Nike and LVMH. | Fundsmith LLP | Terry Smith | 2026 |
| Fundsmith Equity Fund Annual Letter to Shareholders 2025 | Terry Smith reports that Fundsmith Equity rose 0.8% in 2025 against 12.8% for the MSCI World Index, in its sixteenth annual letter. | Fundsmith LLP | Terry Smith | 2025 |
| Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 | Terry Smith reports Fundsmith Equity's first-half 2025 performance against the MSCI World Index and comparators. | Fundsmith LLP | Terry Smith | 2025 |
| Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2023 | Fundsmith's top contributors in the first half of 2023 were Meta, Microsoft, L'Oréal, LVMH and Amadeus; Meta had been a large detractor a year earlier. | Fundsmith LLP | Terry Smith | 2023 |
We exited or have started exiting: Atlas Copco, Coloplast, EssilorLuxottica, Intuit, LVMH, Magnum Ice Cream, Mettler-Toledo, Nike, Novo Nordisk, Otis, Unilever, Wolters Kluwer, and Zoetis.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2026 · Fundsmith LLP · page 7 · 2026
Another Danish medical company, Coloplast, was also amongst our largest detractors.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 · Fundsmith LLP · page 2 · 2025
Coloplast was a company whose revenue growth rate was metronomic.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 · Fundsmith LLP · page 2 · 2025
Both Novo and Coloplast are controlled by foundations which we have seen as a strength in terms of their ability to make good long-term decisions.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 · Fundsmith LLP · page 2 · 2025
Others like Coloplast or IDEXX remain metronome-like in their reliability and generated revenue growth of 8% and 10% respectively.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2023 · Fundsmith LLP · page 5 · 2023